Clinical application of serum Golgi protein 73 in patients with chronic liver diseases / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 4-8, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-935903
ABSTRACT
Golgi protein 73 (GP73) is a transmembrane protein on the Golgi apparatus and can be cut and released into the blood. In recent years, an increasing number of clinical studies have shown that the elevated serum GP73 level is closely related to liver diseases. And thus GP73 is expected to be used as a new serum marker for assessing progress of chronic liver diseases. Herein, the clinical application of serum GP73 in chronic hepatitis, liver fibrosis, liver cirrhosis and hepatocellular carcinoma with different etiologies was reviewed based on available literatures; and a research outlook in this field is made.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Biomarcadores
/
Carcinoma Hepatocelular
/
Aparato de Golgi
/
Cirrosis Hepática
/
Neoplasias Hepáticas
Límite:
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Hepatology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS